Healx3, a Cambridge startup, is planning to take drug development projects parked by biopharmaceutical companies and recycle it into new assets. The company has recently joined Accelerate Cambridge programme and Stevenage Bioscience Catalyst Mentoring Scheme.
Read the full article [businessweekly.co.uk]
Comments